Anastrozole tablet
Formulation (FDF) · tablet · 1mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Anastrozole tablet
- Dosage Form
- tablet
- Strength
- 1mg
- Therapy Area
- Oncology
- Indication
- Advanced breast cancer; Early breast cancer
- Current Status
- Official FDF licensing catalog (UB715)
- GMP Certification
- US - FDA; UK - MHRA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
United StatesChina
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price